Skip to content

Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment

Álvaro París, Luke Lake, Albert Joseph, Anna Workman, Joseph Walton, T. Hayton, N. Evangelou, James B. Lilleker, R. Ayling, D. Nicholl, Alastair J. Noyce

Practical Neurology February 22, 2023 DOI: 10.1136/pn-2022-003631 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Practical guide or manual Peer reviewed
Key points The authors argue that nitrous oxide-induced subacute combined degeneration of the cord (N2O-SACD) is a rising cause of serious, potentially permanent disability in young people that can be treated effectively if recognized early. Because no agreed guidelines exist, they provide practical advice, based on their East London experience, on recognizing, investigating, and treating the condition, and contend that all neurologists should be aware of it.

Abstract

Recreational use of nitrous oxide (N2O) has increased rapidly in recent years and is now the second most commonly used recreational drug among young people in the UK. There has been a corresponding rise in cases of nitrous oxide-induced subacute combined degeneration of the cord (N2O-SACD), a pattern of myeloneuropathy usually associated with severe vitamin B12 deficiency. This can cause serious and permanent disability in young people but, if recognised early, may be effectively treated. All neurologists should be aware of N2O-SACD and its treatment; however, there are currently no agreed guidelines. Based on our experience in East London, an area of high N2O use, we provide practical advice on its recognition, investigation and treatment.

Citations in the library